Caspase-1 boosts immunotherapeutic efficacy via induction of CD8+ T cell cytotoxicity through interleukin-18 secretion in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small cell lung cancer
本文未提供摘要，请点击“查看全文”查看完整内容。